• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biodesix Inc (NQ: BDSX )

    1.330 -0.010 (-0.75%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Biodesix Inc

    < Previous 1 2 3 4 Next >
    Biodesix Announces Third Quarter 2024 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    Biodesix to Participate in Three Investor Conferences in November
    From Biodesix, Inc.
    Via GlobeNewswire
    Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Present at Two Investor Conferences in September
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Second Quarter 2024 Results and Highlights
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in Two Investor Conferences in June
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in Two Upcoming Investor Conferences in November
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Third Quarter 2023 Results and Highlights
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in Two Upcoming Investor Conferences in September
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Second Quarter 2023 Results and Highlights
    From Biodesix, Inc.
    Via Business Wire
    Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
    From Biodesix, Inc.
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.